Regenxbio
RGNX
166 hedge funds and large institutions have $784M invested in Regenxbio in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 65 reducing their positions, and 31 closing their positions.
43% more call options, than puts
Call options by funds: $3.64M | Put options by funds: $2.54M
2.6% less ownership
Funds ownership: 78.89% → 76.29% (-2.6%)
7% less funds holding
Funds holding: 179 → 166 (-13)
23% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 65
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
28% less capital invested
Capital invested by funds: $1.08B → $784M (-$298M)
39% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$11.8M |
| 2 |
FM
Frazier Management
Seattle,
Washington
|
+$5.68M |
| 3 |
Citigroup
New York
|
+$5.06M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$4.36M |
| 5 |
Morgan Stanley
New York
|
+$4.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.86M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.77M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.63M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$5.71M |
| 5 |
SFI
Sonic Fund II
Honolulu,
Hawaii
|
-$4.95M |
RGNX Hedge Fund Activity: Q3 2020 in Review
166 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2020, worth a combined $784M — down 28% from $1.08B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of RGNX and 19 opened new positions — a net loss of 12 holders — while 65 trimmed existing stakes and 50 added.
The largest buyer was UBS Group, adding an estimated $11.8M. The largest seller was Wellington Management Group, cutting an estimated $9.86M.
- 166 institutional investors held Regenxbio (RGNX) as of Q3 2020, down from 179 in Q2 2020.
- Funds reported $784M of Regenxbio stock for Q3 2020, down 28% quarter-over-quarter.
- 19 funds opened new Regenxbio positions in Q3 2020 and 31 closed out, a net change of -12 holders.
- The largest Regenxbio buyer in Q3 2020 was UBS Group, an estimated $11.8M added.
- The largest Regenxbio seller in Q3 2020 was Wellington Management Group, an estimated $9.86M sold.
Based on aggregated 13F filings for Q3 2020.